Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · November 20, 2023

Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 for Type 2 Diabetes

Archives of Endocrinology and Metabolism

 

Additional Info

Archives of Endocrinology and Metabolism
Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
Arch Endocrinol Metab 2023 May 25;67(5)e000614, R Ribeiro E Silva, M de Miranda Gauza, MES Guisso, JON da Silva, SK Kohara

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading